company presentation eigenkapitalforum · 2,000 1,500 1,000 500 0 2008 2009 2010 2011 share buy...
TRANSCRIPT
Company PresentationEigenkapitalforum
November 23rd, 2011Frankfurt am Main
2
• UMS at a Glance
• New Markets and Treatment Forms
• Financials: Actual & Outlook
• The UMS Share
Agenda
3
UMS at a Glance
UMS provides mobile „roll-in, roll-out“ health careservices on a regularly scheduled basis
• Founded 1988 in Quickborn near Hamburg
• UMS today is the leader in the United States for a variety of transportable medical services
• UMS offers advanced mobile medical solutions to hospitals, ambulatory surgery centers and physicians' offices
• Serviceprovider across the United States, as well as in Canada and South America
4
UMS at a Glance
Providemobile
Procedures
• UMS targets clinical procedures where patient volumes do not justify the investment in equipment and personnel
• UMS develops (with manufacturers) medical technologies formobile deployment
Achieve High Utilization
• UMS services numerous clinics and physicians with one mobile system on a fee-per-day basis
• UMS drives asset utilization to up to ten times higher than if themedical center purchased the equipment
Create Quality &
Efficiencies
• High utilization of the system clearly reduces the costs oftreatment per patient
• UMS services benefit hospitals, physicians and patients
5
Physicians
FacilityFee
Medical S
ervices Fee
Technician and E
quipment Fee
Physician Fee
Payor
Partnership ASC
Today: Hospitals and ASCs bill and collect from government and commercial payors
Healthcare Facility
Medical
Services Fee
Managem
ent Fee
UMS at a Glance
6
UMS at a Glance
- Service platform in 34 states and four countries
- Around 28,000 lithotripsy procedures (2010)
- Around 13,500 stereotactic breast biopsy treatments (2010)
- Offer most lithotripsy services through limited partnerships with over 500 physicians
- Low direct payor exposure
- Diversified customer bases of around 650 long-term contracts
Overview of Business
7
UMS at a Glance
Segment Overview
Medical Segment (9/2011) 1-9/2011 Revenue by Segment
Total 2011 Revenue: € 38 – 40 million
Urology- Lithotripsy- Laser- Brachytherapy
Breast Care- Stereotactic
Breast Biopsy
Radiology- MRI
56 units
32 units
7 units
Urology 69%
Breast Care 27% Other 4%
New Markets and Treatments
• Q1/2011: Additional Litho Unit established in CON-State Michigan
• H1/2011: New Litho Partnershipformed in Florida, Virginia, Massachusetts
• Q1/2011: Additional MR unitestablished
• Q2-Q3/2011: Evaluation of thePeru market potential
UMS USA
UMS Canada
UMS Chile
UMS Ecuador
2 countries
34 states
UMS continues to expand the existing business segments organically …
New Markets and Treatments
Breast Surgical Services (Dec. 31, 2010)• US-State Texas• 10 contracts
Mobile Biopsy (Apr. 15, 2011)• South-East U.S.• 50 contracts
2 countries
… and through acquisitions
New Markets and Treatment
• May 2011: UMS partners withIceCure to develop mobile deployment of IceCure‘s medicalproduct IceSense3
• IceSense3 is FDA-approved forthe treatment of benign tumors in the breast
• In the US alone, approximately500,000 of these tumors aresurgically removed each year
2 countries
UMS adapts new technologies to its concepts
11
Revenues 29.4 27.3 28.3 1.0 4%
Gross Profit 14.9 13.8 13.5 -0.3 -2%in % 51% 51% 48%
EBIT 9.7 9.0 8.7 -0.3 -4%
EBITDA 12.4 11.5 11.5 - -
EBITDA – MIN 7.3 7.2 6.8 -0.4 -5%
Net Income 7.5 7.0 6.9 -0.1 -1%
EPS in EUR 0.46 0.43 0.36 -0.06 -15%
Financials: Actual & Outlook
Financial Statements 30/09/2011 – Key Indicators
Q1-Q3/10 Q1-Q3/10 Q1-Q3/11 Changein € millions 1
1currency adjusted
1
1
1
1
1
1
1
12
Financials: Actual & Outlook
89
1011121314151617
Q1 Q2 Q3 Q4
20112010
Earnings per share (€): Q3/11 substantially improved over Q2/11
13
Financials: Actual & Outlook
Fiscal year 2011
2011 forecast: EPS appr. € 0.45 – 0.55 (2010: € 0.61)
Development in 2011 has been adversely affected by- Exchange Rate EUR/USD (2010: 1,32/1-9/2011: 1,41) - Mobile Biopsy Integration Costs- Slow utilization ramp up of third MR unit
UMS has adjusted the earning targets for 2011 accordingly
14
Financials: Actual & Outlook
Fiscal year 2012
Looking ahead to 2012, we expect- significant revenue and earnings improvements in our radiology services
business - full integration of Mobile Biopsy- organic growth in Lithotripsy - significant progress in strategic initiatives (e.g. IceCure Cooperation)- clear improvement over fiscal 2011
15
The UMS Share
UMSS-Dax
Share Price influenced by
- Dividend policy- Earnings expectations- Market volatility
Dividend 2010
Profit warning
16
UMS AG expects to maintain its dividend policy for fiscal year 2011
The UMS Share
pre 2009 2009 2010
EPS: €0.48
EPS: €0.61 EPS target 2011:
€0.45 - €0.55
Dividend per share
€0.50
€0.30
17
The UMS Share
Distribution to shareholders(€ thousands)4,000
3,500
3,000
2,500
2,000
1,500
1,000
500
02008 2009 2010 2011
Share buy back
Dividend
18
Annex
19
Number of shares 4,873,284
Segment Prime Standard
ISIN DE0005493654
Reuters UMS.DE
Stock exchange price Nov. 14th, 2011 6.00 Euro
Market capitalization Nov. 14th, 2011 29.2 Mill. Euro
Average daily turnover (LTM) 6,094 shares
The UMS Share
20
Shareholders actual*
The UMS Share
Free Float: 48.5%
CEO: 7.1%
Thomas J.C. Matzen GmbH: 20.9%Union Investment: 4.4%
Supervisory Board: 11.0%
Capiton Value Bet. GmbH: 8.1%
* nach vorliegenden Mitteilungen von Anteilseignern gemäß denVorschriften des deutschen Wertpapierhandelsgesetzes (WpHG)
21
Financial CalendarMarch 2012: Preliminary Results 2011
April 2012: Annual Report 2011
May 15, 2012: Interim Report Q1/2012
May 31, 2012: Annual Shareholders‘ Meeting, Hamburg
August 14, 2012: Interim Report Q2/2012
The UMS Share
22
Executive Board:Jorgen Madsen, CEO
Investor Relations:Wiebke Budwaschfon: +49 40 50 01 77 00fax: + 49 40 50 01 77 77 e-mail: [email protected] Internet: www.umsag.com
edicto GmbHAxel Mühlhaus/Werner Rüppelfon: +49 69 905505 – 52fax: +49 69 905505 – 77e-mail: [email protected]
UMS United Medical Systems International AGBorsteler Chaussee 53 D – 22453 Hamburg
UMS